Vital Signs - Benchtop Automation: Accelerating Bench to Bedside
Vital Signs - Benchtop Automation: Accelerating Bench to Bedside
RELEASE DATE
25-Apr-2011
25-Apr-2011
REGION
North America
North America
Research Code: 9561-00-C4-00-00
SKU: HC00623-NA-MR_04096
$1,500.00
In stock
SKU
HC00623-NA-MR_04096
Description
This issue of Vital Signs, released on April 25, 2011, provides analyts's summary of the American Association of Cancer Research (AACR) annual meeting.
Additionally, a company spotlight is provided for QuantaLife, a venture-backed startup company based in Pleasanton, Calif., developing third-generation of Polymerase Chain Reaction (PCR) technology that provides an absolute quantification measurement of target molecules in nanoliter droplet form. Reimbursement and regulatory news from the FDA is also provided for week of April 4, 2011.
Table of Contents
This week's issue
Related Research
Popular Topics
This issue of Vital Signs, released on April 25, 2011, provides analyts's summary of the American Association of Cancer Research (AACR) annual meeting. Additionally, a company spotlight is provided for QuantaLife, a venture-backed startup company based in Pleasanton, Calif., developing third-generation of Polymerase Chain Reaction (PCR) technology that provides an absolute quantification measurement of target molecules in nanoliter droplet form. Reimbursement and regulatory news from the FDA is also provided for week of April 4, 2011.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-C4-00-00 |
Is Prebook | No |